drugset / Trial / NCT00528918

Comparison of Apidra to Regular Insulin in Hospitalized Patients

NCT00528918

RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to compare Apidra (a rapid acting insulin analogue) with Regular insulin (fast acting) in addition to the use of long acting insulin Glargine in hospitalized patients in terms of efficacy and safety in blood glucose control and frequency of low blood glucose. Blood glucose control along with incidence and rate of low blood glucose during the hospitalization shall be of primary interest; length of hospital stay comparing the short acting insulin used shall be the secondary interest.

Timeline

Start
2007-06
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin glulisine Protein / enzyme biologic 0.2 iu/kg
Comparator Insulin glulisine Protein / enzyme biologic 0.25 iu/kg
Comparator Insulin glulisine Protein / enzyme biologic 0.3 iu/kg